DADC
ALBO

D.A. Davidson & Co’s Albireo Pharma Inc ALBO Stock Holding History

D.A. Davidson & Co’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17
Closed – – 2313
2015
Q2 		$0 Hold
17
– – ﹤0.01% 2318
2015
Q1 		$0 Hold
17
– – ﹤0.01% 2182
2014
Q4 		$0 Hold
17
– – ﹤0.01% 2203
2014
Q3 		$0 Hold
17
– – ﹤0.01% 2198
2014
Q2 		$1K Hold
17
– – ﹤0.01% 2071
2014
Q1 		$1K Hold
17
– – ﹤0.01% 2076
2013
Q4 		$1K Hold
17
– – ﹤0.01% 2020
2013
Q3 		$1K Buy
+17
New +$2.21K ﹤0.01% 1707

Other funds holding ALBO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.A. Davidson & Co's ALBO Position: Q3 2015 in Review

D.A. Davidson & Co sold out of Albireo Pharma Inc (ALBO) in Q3 2015, closing a stake of 17 shares.

D.A. Davidson & Co first reported a position in ALBO in Q3 2013 and held it in 8 quarters. The position peaked at $1K in Q2 2014. 38 funds tracked by Wall St. Rank hold ALBO as of Q3 2015.

  • D.A. Davidson & Co reported no remaining Albireo Pharma Inc position as of Q3 2015 after selling out during the quarter.
  • D.A. Davidson & Co sold 17 Albireo Pharma Inc shares in Q3 2015.
  • D.A. Davidson & Co first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 8 quarters.
  • D.A. Davidson & Co's Albireo Pharma Inc position peaked at $1K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2015.

Based on D.A. Davidson & Co's 13F filing for Q3 2015, filed 13 Nov 2015.